Tue, May 9, 2023

Douglas Tsao Maintained (TBPH) at Strong Buy with Increased Target to $20 on, May 9th, 2023

Douglas Tsao of HC Wainwright & Co., Maintained "Theravance Biopharma, Inc." (TBPH) at Strong Buy with Increased Target from $19 to $20 on, May 9th, 2023.

Douglas, nor any peers, have made any analyst calls on TBPH in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30